Compare PHR & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHR | SCL |
|---|---|---|
| Founded | 2005 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2019 | N/A |
| Metric | PHR | SCL |
|---|---|---|
| Price | $16.71 | $48.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $31.88 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 161.8K |
| Earning Date | 12-08-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.98 |
| Revenue | $463,205,000.00 | ★ $2,303,837,000.00 |
| Revenue This Year | $14.91 | $8.79 |
| Revenue Next Year | $12.07 | $8.14 |
| P/E Ratio | ★ N/A | $24.25 |
| Revenue Growth | ★ 14.33 | 5.35 |
| 52 Week Low | $15.41 | $41.82 |
| 52 Week High | $32.76 | $75.65 |
| Indicator | PHR | SCL |
|---|---|---|
| Relative Strength Index (RSI) | 31.28 | 66.71 |
| Support Level | $15.41 | $44.53 |
| Resistance Level | $17.18 | $48.83 |
| Average True Range (ATR) | 1.04 | 1.22 |
| MACD | -0.33 | 0.45 |
| Stochastic Oscillator | 22.30 | 86.32 |
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.